Indication
Leptomeningeal Carcinomatosis
1 clinical trial
1 product
Product
RTA 744Clinical trial
A Phase I Safety and Pharmacokinetic Study of Intravenous RTA 744 Injection in Patients With Recurrent, Progressive or Refractory Neoplastic MeningitisStatus: , Estimated PCD: 2008-12-01